Journal profile · Endocrinology & Metabolism
Acta Diabetologica
ISSN 0940-5429 · eISSN 1432-5233 · Springer Milan · ITALY · Quarterly · Founded 1964
Acta Diabetologica: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.11; hybrid open access; APC about USD 4,590; median 88 days to acceptance (97 articles, last 24 months); community-reported acceptance: about 50%; 189 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Acta Diabetologica is published by Springer Milan and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Diabetes Management and Research, Diabetes and associated disorders and Pancreatic function and diabetes, together about 34.7% of its articles. Its main subfields are Endocrinology, Diabetes and Metabolism. (generated from OpenAlex topic counts and CAS ranking data)
Acta Diabetologica is a journal that publishes reports of experimental and clinical research on diabetes mellitus and related metabolic diseases. Original contributions on biochemical, physiological, pathophysiological and clinical aspects of research on diabetes and metabolic diseases are welcome. Reports are published in the form of original articles, short communications and letters to the editor. Invited reviews and editorials are also published. A Methodology forum, which publishes contributions on methodological aspects of diabetes in vivo and in vitro, is also available. The Editor-in-chief will be pleased to consider articles describing new techniques (e.g., new transplantation methods, metabolic models), of innovative importance in the field of diabetes/metabolism. Finally, workshop reports are also welcome in Acta Diabetologica. Manuscripts submitted for publication must contain a statement to the effect that all human studies have been reviewed by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in an appropriate version of the 1964 Declaration of Helsinki. It should also be stated clearly in the text that all persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identity of the subjects under study should be omitted. Reports of animal experiments must state that the "Principles of laboratory animal care" (NIH publication No. 86-23, revised 1985) were followed, as well as specific national laws (e.g. the current version of the German Law on the Protection of Animals) where applicable. The Editor-in-chief reserves the right to reject manuscripts that do not comply with the above-mentioned requirements. The author will be held responsible for false statements or for failure to fulfil the above-mentioned requirements. The journal is open for publication of supplements and for publishing abstract s of scientific meetings. Condition can be obtained from the Editor-in Chief or the publisher. Founding Editor G Pozza, Milan (Italy) Honorary Editor R Lauro, Rome (Italy)
From the journal's Aims & Scope
Research area (LetPub): Endocrinology & Metabolism
Editor-in-chief Massimo FedericiPublisher website
Editorial board by country: none in mainland China; most named Italy 25, United States 2, Germany 1, Australia 1, Belgium 1 (32 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Diabetes Management and ResearchMedicine13.3%
- Diabetes and associated disordersBiochemistry, Genetics and Molecular Biology11.2%
- Pancreatic function and diabetesMedicine10.2%
- Diabetes, Cardiovascular Risks, and LipoproteinsMedicine7.9%
- Diabetes Treatment and ManagementMedicine7.8%
- Metabolism, Diabetes, and CancerBiochemistry, Genetics and Molecular Biology5.1%
- Diet and metabolism studiesMedicine4.2%
- Hyperglycemia and glycemic control in critically ill and hospitalized patientsMedicine4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASCAB AbstractsCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.11LetPub ·
- Impact factor (publisher) 2025
- 3.1Publisher website ·
- 5-year impact factor (publisher) 2025
- 3.2Publisher website ·
- CiteScore 2026-06
- 5.7LetPub ·
- SJR 2026-06
- 1.01LetPub ·
- SNIP 2026-06
- 1.01LetPub ·
- h-index
- 56LetPub ·
- h-index
- 108OpenAlex ·
- i10-index
- 2,127OpenAlex ·
- 2-year mean citedness
- 3OpenAlex ·
- Self-citation rate
- 3.2%LetPub ·
- Share of gold OA articles
- 34.02%LetPub ·
Volume
- Articles per year
- 169LetPub ·
- Downloads per year (publisher) 2025
- 870,100Publisher website ·
Articles by year OpenAlex count · 4,993 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 168 | 61 | 48 |
| 2025 | 189 | 64 | 552 |
| 2024 | 211 | 80 | 1,106 |
| 2023 | 198 | 91 | 1,964 |
| 2022 | 190 | 98 | 2,377 |
| 2021 | 188 | 103 | 3,793 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
88 daysMedian, submission to acceptance · P25–P75 60 days – 128 days
- Acceptance to online
- median 26 days (98 articles)
- Submission to online
- median 124 days
- Sample
- 97 articles with submission and acceptance dates (414 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 2 monthsLetPub ·
- Average acceptance (community reports)
- 50%LetPub ·
- Submission to first decision
- 8 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,590 / EUR 3,590 / GBP 2,890 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Optional
Article types accepted13, with length limits
- case reporton. Up to 45 references are permitted.. Case reports They must not exceed 2,000 words, 5 references and 5 authors. They should not have an abstramain text ≤ 2,000 words
- case reportsThey must not exceed 2,000 words, 5 references and 5 authors. They should not have an abstract, not include more than 2 illustrations.Length not stated
- editorialIt is the policy of Acta Diabetologica to ensure balance, independence, objectivity and scientific rigor in the journal. All authors are expected to disclose to…Length not stated
- editorialsEditorials are usually written by members of the Editorial and Advisory Board. They should not exceed 500 words, not include more than 1 illustration and refere…Length not stated
- letters to the editorsLetters to the editors must not exceed 600 words (and 5 references) with one table or figure and without abstracts. They should be addressed to the Editors-in-C…Length not stated
- meta-analysisIt is the policy of Acta Diabetologica to ensure balance, independence, objectivity and scientific rigor in the journal. All authors are expected to disclose to…Length not stated
- original papersOriginal papers should have a structured abstract (Aims, Methods, Results and Conclusions), must not exceed 3,000 words and should not include more than 6 illus…Length not stated
- position statementA position statement is written by experts on a specific topic of interest in the clinical practice of diabetes and associated disorders.Length not stated
- reviewIt is the policy of Acta Diabetologica to ensure balance, independence, objectivity and scientific rigor in the journal. All authors are expected to disclose to…Length not stated
- review articleIt is the policy of Acta Diabetologica to ensure balance, independence, objectivity and scientific rigor in the journal. All authors are expected to disclose to…Length not stated
- short communicationnot include more than 2 illustrations. Short communications They must not exceed 1,000 words, should not have an abstract. They should not exceed 1,000main text ≤ 1,000 words
- short communicationsThey must not exceed 1,000 words, should not have an abstract. They should not exceed 1,000 words; 2 illustrations and up to 5 references are permitted.Length not stated
- systematic reviewIt is the policy of Acta Diabetologica to ensure balance, independence, objectivity and scientific rigor in the journal. All authors are expected to disclose to…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Conflict of interest
Authors must indicate whether or not they have a financial relationship with the organization that sponsored the research. This note should be added in a separate section before the reference list. If no conflict exists, authors should state: The authors declare that they have no conflict of interest. Back to top
Source ↗Publisher website ·- Data availability Data availability
Data transparency expected Model summary
The journal encourages authors to provide a statement of Data availability in their article. Data availability statements should include information on where data supporting the results reported in the article can be found, including, where applicable, hyperlinks to publicly archived datasets analysed or generated during the study. Data availability statements can also indicate whether data are av…
Source ↗Publisher website ·- Publication ethics Ethical standards
Ethics committee approval and Declaration of Helsinki compliance required Model summary
Manuscripts submitted for publication must contain a statement to the effect that all human and animal studies have been approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. It should also be stated clearly in the text that all persons gave their informed conse…
Source ↗Publisher website ·- License & copyright Copyright
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Acta Diabetologica, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Peer review
Reviewer suggestions and exclusions allowed at submission Model summary
Authors are welcome to suggest suitable reviewers and/or request the exclusion of certain individuals when they submit their manuscripts.
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
Clinical trial registration required with ICMJE-approved registry Model summary
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Milan
- Country or region
- ITALY
- Language
- English
- Frequency
- Quarterly
- Founded
- 1964
- ISSN
- 0940-5429
- Electronic ISSN
- 1432-5233
- Latest issue on the website
- Volume 63, Issue 9 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Acta Diabetologica
What CAS zone is Acta Diabetologica in?
In the 2025 upgraded edition of the CAS Journal Ranking, Acta Diabetologica is in Zone 3 of Medicine, and in Zone 3 of the minor category Endocrinology & Metabolism. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Acta Diabetologica?
The latest impact factor listed by LetPub is 3.11; CiteScore 5.7, h-index 108.
How long does peer review take at Acta Diabetologica?
Based on the dates recorded on 97 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 88 days (interquartile range 60–128 days); authors report an average review time of about 2 months; the community-reported acceptance is “about 50%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Acta Diabetologica?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Reference style: Numbered, in order of citation; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Acta Diabetologica based?
Of the 32 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Italy (25), United States (2) and Germany (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Acta Diabetologica?
According to LetPub and DOAJ records, Acta Diabetologica is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, Embase, CAS, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is Acta Diabetologica open access, and what is the APC?
Acta Diabetologica is a hybrid journal. For open-access publication: APC about USD 4,590.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .